Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06723743 · ClinicalTrials.gov registry record · NA
Transcutaneous Vagus Nerve Stimulation for Attention and Memory
A NA study of Traumatic Brain Injury (TBI) Patients, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT06723743 is a NA study of Traumatic Brain Injury (TBI) Patients that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 30 participants, below the 188-participant average among 4 other Traumatic Brain Injury (TBI) Patients trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06723743, a NA study of Traumatic Brain Injury (TBI) Patients, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial aims to evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive brain stimulation method, can improve attention and memory in veterans with traumatic brain injury (TBI) and depression and/or posttraumatic stress disorder (PTSD). The study seeks to answer two main questions: 1. Can active taVNS improve attention and memory compared to sham (placebo) stimulation? 2. Does taVNS affect heart rate variability (HRV)? taVNS delivers a gentle electrical current to the vagus nerve through electrodes placed on the ear, targeting brain areas involved in attention and memory without requiring surgery. This study uses a crossover design, meaning all participants will experience two sessions: one with active taVNS and one with sham stimulation. The sham session feels similar but does not deliver actual stimulation, allowing researchers to compare the two and understand taVNS's effects on the brain. In a single visit, participants will: * Complete eligibility screening (questionnaires and vital signs). * Undergo two sessions (one active and one sham), randomly assigned. * Perform attention tasks before and after each session. * Have their heart rate monitored during the sessions. The findings will help determine whether taVNS could be an effective treatment for improving attention and memory in veterans with TBI.
Conditions Studied
Interventions
- OTHER Transcutaneous vagus nerve stimulation for attention in veterans with TBI
- DEVICE Soterix Medical Vagus Nerve Stimulation mini-CT
Study Locations (2)
Texas
- Michael E. DeBakey VA Medical Center - Houston
- Michael E. DeBakey VA Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-11 |
| Est. Completion | 2026-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06723743
The ClinicalTrials.gov registry entry for NCT06723743 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 4 other Traumatic Brain Injury (TBI) Patients trials with a reported enrollment target (84% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Brain Injury (TBI) Patients appearing as the primary indexed condition, and to 2 interventions - of which Transcutaneous vagus nerve stimulation for attention in veterans with TBI is the first listed.
NCT06723743 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06723743 about?
NCT06723743 is a clinical study titled "Transcutaneous Vagus Nerve Stimulation for Attention and Memory". This clinical trial aims to evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive brain stimulation method, can improve attention and memory in veterans with traumatic brain injury (TBI) and depression and/or posttraumatic stress disorder (PTSD). The study seeks t...
What is the current status of trial NCT06723743?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-11. Estimated completion is 2026-02.
What conditions does trial NCT06723743 study?
This clinical trial studies the following conditions: Traumatic Brain Injury (TBI) Patients.
What interventions are being tested in trial NCT06723743?
The interventions under investigation include: Transcutaneous vagus nerve stimulation for attention in veterans with TBI (OTHER), Soterix Medical Vagus Nerve Stimulation mini-CT (DEVICE).
Who is sponsoring clinical trial NCT06723743?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06723743 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury (TBI) Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Neuromodulation in Traumatic Brain Injury
RECRUITING · NA
-
Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury
RECRUITING · NA
-
External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients
RECRUITING · NA
-
Saline Versus Balanced Crystalloid in Traumatic Brain Injury
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.